That said, there's useful general context from published clinical guidelines worth knowing before you fill out an intake form
"NAION is a very rare eye disease, and it is not an adverse drug reaction for the marketed formulations of semaglutide (Ozempic, Rybelsusand Wegovy) as per the approved labels
Semaglutide is an FDA-approved medication that has shown significant effectiveness in weight management
Side effects are another important consideration
Some analysts and industry observers expect that an FDA decision may not occur until late 2026 or 2027, assuming all safety and efficacy endpoints are met
Key results included: Sustained improvements in skin quality, hydration, and radiance Over 88% of participants loved how treatment maintained their facial structure 9 out of 10 participants would recommend it after GLP-1 weight loss Visible improvements lasting up to 9 months Sculptra stimulates collagen and gradually improves laxity, while HA fillers restore immediate structure in areas that flatten with weight loss